Page last updated: 2024-10-26

valproic acid and Xerophthalmia

valproic acid has been researched along with Xerophthalmia in 1 studies

Valproic Acid: A fatty acid with anticonvulsant and anti-manic properties that is used in the treatment of EPILEPSY and BIPOLAR DISORDER. The mechanisms of its therapeutic actions are not well understood. It may act by increasing GAMMA-AMINOBUTYRIC ACID levels in the brain or by altering the properties of VOLTAGE-GATED SODIUM CHANNELS.
valproic acid : A branched-chain saturated fatty acid that comprises of a propyl substituent on a pentanoic acid stem.

Xerophthalmia: Dryness of the eye surfaces caused by deficiency of tears or conjunctival secretions. It may be associated with vitamin A deficiency, trauma, or any condition in which the eyelids do not close completely.

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (100.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Boyle, NJ1
Clarke, MP1
Figueiredo, F1

Other Studies

1 other study available for valproic acid and Xerophthalmia

ArticleYear
Reduced corneal sensation and severe dry eyes in a child with fetal valproate syndrome.
    Eye (London, England), 2001, Volume: 15, Issue:Pt 5

    Topics: Anticonvulsants; Corneal Diseases; Female; Humans; Hypesthesia; Infant, Newborn; Pregnancy; Prenatal

2001